title: Influence of 3-hydroxymethyl xylitol, a novel antidiabetic compound isolated from Casearia esculenta (Roxb.) root, on glycoprotein components in streptozotocin-diabetic rats.
abstract: Casearia esculenta root (Roxb.) is widely used in traditional system of medicine to treat diabetes in India. An active compound, 3-hydroxymethyl xylitol (3-HMX), has been isolated, and its optimum dose has been determined in a short duration study and patented. In addition, the long-term effect of 3-HMX in type 2 diabetic rats on antihyperglycemic, antioxidants, antihyperlipidemic, and protein metabolism and kidney marker enzymes was investigated, and its effect was shown previously. In this study, we investigated the effect of 3-HMX on plasma and tissue glycoproteins in streptozotocin-diabetic rats. Animals were divided into five groups viz., control group, 3-HMX (40 mg/kg of body weight) treated group, diabetic group, diabetic+3-HMX (40 mg/kg of body weight), and diabetic+glibenclamide (600 μg/kg of body weight). 3-HMX was administered orally at a dose of 40 mg/kg of body weight for 45 days. The study shows significant increases in the level of sialic acid except kidney and elevated levels of hexose, hexosamine, and fucose in the liver and kidney of diabetic rats, and the treatment with 3-HMX and glibenclamide showed reversal of these parameters toward normalcy. Thus, the study indicates that 3-HMX possesses a significant beneficial effect on glycoprotein components.
authors.affiliation: Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
authors.forename: Chandramohan
authors.initials: C
authors.lastname: Govindasamy
authors.forename: Khalid S
authors.initials: KS
authors.lastname: Al-Numair
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Alsaif
authors.forename: Kodukkur Pugalendi
authors.initials: KP
authors.lastname: Viswanathan
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D037821:Casearia / Q000737:chemistry*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D005353:Fibronectins / Q000096:biosynthesis / Q000187:drug effects; D005905:Glyburide / Q000627:therapeutic use; D006021:Glycophorins / Q000187:drug effects / Q000378:metabolism; D006023:Glycoproteins / Q000097:blood; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology*; D007328:Insulin / Q000097:blood; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D009439:Neuraminidase / Q000187:drug effects / Q000378:metabolism; D018517:Plant Roots / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar; D013311:Streptozocin / Q000494:pharmacology*; D014993:Xylitol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology
chemical_list: C532178:3-hydroxymethylxylitol; D001786:Blood Glucose; D005353:Fibronectins; D006021:Glycophorins; D006023:Glycoproteins; D007004:Hypoglycemic Agents; D007328:Insulin; D013311:Streptozocin; D009439:Neuraminidase; D005905:Glyburide; D014993:Xylitol